Central venous catheter-associated Nocardia bacteremia in cancer patients

Emerging Infectious Diseases

Volumn 17, Issue 9, 2011, Pages 1651-1658

  Al Akhrass, Fadi ^a   Hachem, Ray ^a   Mohamed, Jamal A ^a   Tarrand, Jeffrey ^a   Kontoyiannis, Dimitrios P ^a   Chandra, Jyotsna ^b,c   Ghannoum, Mahmoud ^b,c   Haydoura, Souha ^d   Chaftari, Ann Marie ^a   Raad, Issam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d University School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFTRIAXONE; COTRIMOXAZOLE; EDETIC ACID; MINOCYCLINE; TRIMETHOPRIM;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BIOFILM; CANCER PATIENT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG POTENCY; FEMALE; HUMAN; IN VITRO STUDY; MALE; NOCARDIOSIS; PROGNOSIS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMS; BIOFILMS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MICROSCOPY, ELECTRON, SCANNING; NEOPLASMS; NOCARDIA INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 80052156370     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1709.101810     Document Type: Article

References (34)

1. Brown JM, McNeil M. Nocardia, Rhodococcus, Gordonia, Actinomadura, Streptomyces, and other aerobic actinomycetes. In: L Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology, 8th ed. Washington: American Society for Microbiology; 2003. p. 370-98.
2. Lerner PI. Nocardiosis. Clin Infect Dis. 1996;22:891-903, quiz 904-5 doi:10.1093/clinids/22.6.891.
3. Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7:213-64.
4. McNeil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7:357-417.
5. Kontoyiannis DP, Ruoff K, Hooper DC. Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine (Baltimore). 1998;77:255-67. doi:10.1097/00005792-199807000-00004.
6. Lui WY, Lee AC, Que TL. Central venous catheter-associated Nocardia bacteremia. Clin Infect Dis. 2001;33:1613-4. doi:10.1086/323557.
7. Torres HA, Reddy BT, Raad II, Tarrand J, Bodey GP, Hanna HA, et al. Nocardiosis in cancer patients. Medicine (Baltimore). 2002;81:388-97. doi:10.1097/00005792-200209000-00004.
8. Kontoyiannis DP, Jacobson KL, Whimbey EE, Rolston KV, Raad II. Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis. 2000;31:617-8. doi:10.1086/313941.
9. Centers for Disease Control and Prevention. Central line-associated bloodstream infection (CLABSI) event [cited 2011 Jun 1]. http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf
10. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45. doi:10.1086/599376.
11. Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identifi cation and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14:908-34. doi:10.1111/j.1469-0691.2008.02070.x
12. Steingrube VA, Brown BA, Gibson JL, Wilson RW, Brown J, Blacklock Z, et al. DNA amplifi cation and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex. J Clin Microbiol. 1995;33:3096-101.
13. Clinical and Laboratory Standards Institute. Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A. Wayne (PA): The Institute; 2003.
14. Hanna H, Bahna P, Reitzel R, Dvorak T, Chaiban G, Hachem R, et al. Comparative in vitro effi cacies and antimicrobial durabilities of novel antimicrobial central venous catheters. Antimicrob Agents Chemother. 2006;50:3283-8. doi:10.1128/AAC.01622-05.
15. Raad I, Hanna H, Dvorak T, Chaiban G, Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofi lm. Antimicrob Agents Chemother. 2007;51:78-83. doi:10.1128/AAC.00154-06.
16. Chandra J, Mukherjee PK, Ghannoum MA. In vitro growth and analysis of Candida biofi lms. Nat Protoc. 2008;3:1909-24. doi:10.1038/ nprot.2008.192.
17. Wallace RJ Jr, Tsukamura M, Brown BA, Brown J, Steingrube VA, Zhang YS, et al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol. 1990;28:2726-32.
18. Conville PS, Brown JM, Steigerwalt AG, Lee JW, Byrer DE, Anderson VL, et al. Nocardia veterana as a pathogen in North American patients. J Clin Microbiol. 2003;41:2560-8. doi:10.1128/ JCM.41.6.2560-2568.2003.
19. Roth A, Andrees S, Kroppenstedt RM, Harmsen D, Mauch H. Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classifi ed as Nocardia asteroides into three established species and two unnamed taxons. J Clin Microbiol. 2003;41:851-6. doi:10.1128/ JCM.41.2.851-856.2003.
20. Wallace RJ Jr, Brown BA, Tsukamura M, Brown JM, Onyi GO. Clinical and laboratory features of Nocardia nova. J Clin Microbiol. 1991;29:2407-11.
21. Tuo MH, Tsai YH, Tseng HK, Wang WS, Liu CP, Lee CM. Clinical experiences of pulmonary and bloodstream nocardiosis in two tertiary care hospitals in northern Taiwan, 2000-2004. J Microbiol Immunol Infect. 2008;41:130-6.
22. Lai CH, Chi CY, Chen HP, Lai CJ, Fung CP, Liu CY. Port-A catheter-associated Nocardia bacteremia detected by gallium infl ammation scan: a case report and literature review. Scand J Infect Dis. 2004;36:775-7.
23. Saubolle MA, Sussland D. Nocardiosis: review of clinical and laboratory experience. J Clin Microbiol. 2003;41:4497-501. doi:10.1128/JCM.41.10.4497-4501.2003.
24. Benoit JL, Carandang G, Sitrin M, Arnow PM. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis. 1995;21:1286-8. doi:10.1093/clinids/21.5.1286.
25. Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2004;24:491-5. doi:10.1016/j.ijantimicag.2004.06.006.
26. Raad I, Buzaid A, Rhyne J, Hachem R, Darouiche R, Safar H, et al. Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis. 1997;25:149-51. doi:10.1086/514518.
27. Root JL, McIntyre OR, Jacobs NJ, Daghlian CP. Inhibitory effect of disodium EDTA upon the growth of Staphylococcus epidermidis in vitro: relation to infection prophylaxis of Hickman catheters. Antimicrob Agents Chemother. 1988;32:1627-31.
28. Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ. Comparative evaluation of the E test for susceptibility testing of Nocardia species. Diagn Microbiol Infect Dis. 1994;19:101-10. doi:10.1016/0732-8893(94)90120-1.
29. Ambaye A, Kohner PC, Wollan PC, Roberts KL, Roberts GD, Cockerill FR III. Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex. J Clin Microbiol. 1997;35:847-52.
30. Gomez-Flores A, Welsh O, Said-Fernandez S, Lozano-Garza G, Tavarez-Alejandro RE, Vera-Cabrera L. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother. 2004;48:832-7. doi:10.1128/AAC.48.3.832-837.2004.
31. Brown-Elliott BA, Ward SC, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother. 2001;45:1295-7. doi:10.1128/AAC.45.4.1295-1297.2001.
32. Glupczynski Y, Berhin C, Janssens M, Wauters G. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect. 2006;12:905-12. doi:10.1111/j.1469-0691.2006.01460.x
33. Wallace RJ Jr, Steele LC, Sumter G, Smith JM. Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother. 1988;32:1776-9.
34. Tomlin P, Sand C, Rennie RP. Evaluation of E test, disk diffusion and broth microdilution to establish tentative quality control limits and review susceptibility breakpoints for two aerobic actinomycetes. Diagn Microbiol Infect Dis. 2001;40:179-86. doi:10.1016/S0732-8893(01)00273-5